American Century Companies’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,381
Closed -$35.3K 2848
2025
Q1
$35.3K Sell
17,381
-207
-1% -$420 ﹤0.01% 2875
2024
Q4
$106K Buy
17,588
+2,186
+14% +$13.2K ﹤0.01% 2835
2024
Q3
$108K Buy
+15,402
New +$108K ﹤0.01% 2830